Prognostic biomarker RASSF1 in head and neck squamous cell carcinoma

Prognostic biomarker RASSF1 in head and neck squamous cell carcinoma

Bibliographic Details
Main Authors:	Yishimei Si, Linghan Meng, Bingwen Zhang, Jianwei Qi
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Asian Journal of Surgery
Subjects:	HNSCC RASSF1 Prognosis Clinical features
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958423006024

Similar Items

Prognostic biomarker SPP1 in head and neck squamous cell carcinoma
by: Linghan Meng, et al.
Published: (2023-12-01)

Investigation of RASSF4 gene in head and neck cancers
by: Karagedik Emine H., et al.
Published: (2021-09-01)

Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma
by: Meng Ye, et al.
Published: (2017-04-01)

CERCAM is a prognostic biomarker associated with immune infiltration of macrophage M2 polarization in head and neck squamous carcinoma
by: Ying Yang, et al.
Published: (2023-10-01)

Prognostic Value of a Ferroptosis-Related Gene Signature in Patients With Head and Neck Squamous Cell Carcinoma
by: Dongsheng He, et al.
Published: (2021-11-01)

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1
by: Natalia Volodko, et al.
Published: (2016-06-01)

Construction of a combined hypoxia and EMT index for head and neck squamous cell carcinoma
by: Huan Li, et al.
Published: (2022-08-01)

TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma
by: Yaodong He, et al.
Published: (2022-12-01)

The long non-coding RNA ANRASSF1 in the regulation of alternative protein-coding transcripts RASSF1A and RASSF1C in human breast cancer cells: implications to epigenetic therapy
by: Naiade Calanca, et al.
Published: (2019-08-01)

Hypomethylation and downregulation of miR-23b-3p are associated with upregulated PLAU: a diagnostic and prognostic biomarker in head and neck squamous cell carcinoma
by: Zirong Huo, et al.
Published: (2021-10-01)

The prognostic value of LAYN in HPV-related head and neck squamous cell carcinoma and its influence on immune cell infiltration
by: Qingjuan Chen, et al.
Published: (2024-03-01)

B cells in head and neck squamous cell carcinoma: current opinion and novel therapy
by: Xinyue Guo, et al.
Published: (2024-01-01)

Inflammation-Related Gene Signature for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma
by: Lu Y, et al.
Published: (2022-05-01)

Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers
by: Marc Riffet, et al.
Published: (2021-11-01)

Prognostic value of lipid metabolism‐related genes in head and neck squamous cell carcinoma
by: Ying Xiong, et al.
Published: (2021-03-01)

Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
by: Zhi-Min Yang, et al.
Published: (2022-07-01)

Epigenetically inactivated RASSF1A as a tumor biomarker
by: Dora Raos, et al.
Published: (2021-08-01)

Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma
by: Shixian Liu, et al.
Published: (2022-10-01)

A hypoxia‐related lncRNA model for prediction of head and neck squamous cell carcinoma prognosis
by: Junwei Xiang, et al.
Published: (2023-02-01)

An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma
by: Dayang Chen, et al.
Published: (2021-09-01)

A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration
by: Hao Chi, et al.
Published: (2022-08-01)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
by: Gang Xu, et al.
Published: (2020-11-01)

RASSF-1A modulates proliferation-mediated oral squamous cell carcinoma progression
by: Jianli Sun
Published: (2019-08-01)

Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma
by: Antje M. Richter, et al.
Published: (2013-11-01)

BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma
by: Xue Pan, et al.
Published: (2023-01-01)

Methylation Dynamics of <i>RASSF1A</i> and Its Impact on Cancer
by: Giorgio Malpeli, et al.
Published: (2019-07-01)

Research Progress of Ferroptosis in Head and Neck Squamous Cell Carcinoma
by: XIE Zhanghong, et al.
Published: (2022-04-01)

Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma
by: Dan Liu, et al.
Published: (2023-01-01)

Mining TCGA database for prognostic genes in head and neck squamous cell carcinoma microenvironment
by: Qiu-Chi Ran, et al.
Published: (2021-03-01)

Kindlin-3 and RASSF6 are probable biomarkers for predicting metastasis in cutaneous melanoma
by: Onder Bozdogan, et al.
Published: (2022-01-01)

Identification of a Cancer Stem Cells Signature of Head and Neck Squamous Cell Carcinoma
by: Zeng-Hong Wu, et al.
Published: (2022-05-01)

Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas
by: Yujie Shen, et al.
Published: (2022-10-01)

Prognostic Factors for the Therapeutic Performance of Cisplatin in Head and Neck Malignancies
by: Frederic Jungbauer, et al.
Published: (2022-04-01)

RASSF1A and the rs2073498 cancer associated SNP
by: Geoff eClark
Published: (2011-12-01)

Human Leucocyte Antigens as Prognostic Markers in Head and Neck Squamous Cell Carcinoma
by: Gerhard Dyckhoff, et al.
Published: (2022-08-01)

Clinical Implications of Promoter Hypermethylation in RASSF1A and MGMT in Retinoblastoma
by: Kwong Wai Choy, et al.
Published: (2005-03-01)

Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy
by: Morena Fasano, et al.
Published: (2022-01-01)

Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma
by: Bijan Khademi, et al.
Published: (2013-06-01)

RASSF1C modulates the expression of a stem cell renewal gene, PIWIL1
by: Reeves Mark E, et al.
Published: (2012-05-01)

Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma
by: Imelda Seminerio, et al.
Published: (2019-02-01)